201 related articles for article (PubMed ID: 20526532)
1. Regulation of Skp2 expression and activity and its role in cancer progression.
Chan CH; Lee SW; Wang J; Lin HK
ScientificWorldJournal; 2010 Jun; 10():1001-15. PubMed ID: 20526532
[TBL] [Abstract][Full Text] [Related]
2. Novel roles of Skp2 E3 ligase in cellular senescence, cancer progression, and metastasis.
Wang G; Chan CH; Gao Y; Lin HK
Chin J Cancer; 2012 Apr; 31(4):169-77. PubMed ID: 22200179
[TBL] [Abstract][Full Text] [Related]
3. Foxo3a transcription factor is a negative regulator of Skp2 and Skp2 SCF complex.
Wu J; Lee SW; Zhang X; Han F; Kwan SY; Yuan X; Yang WL; Jeong YS; Rezaeian AH; Gao Y; Zeng YX; Lin HK
Oncogene; 2013 Jan; 32(1):78-85. PubMed ID: 22310285
[TBL] [Abstract][Full Text] [Related]
4. Phosphorylation-dependent regulation of cytosolic localization and oncogenic function of Skp2 by Akt/PKB.
Lin HK; Wang G; Chen Z; Teruya-Feldstein J; Liu Y; Chan CH; Yang WL; Erdjument-Bromage H; Nakayama KI; Nimer S; Tempst P; Pandolfi PP
Nat Cell Biol; 2009 Apr; 11(4):420-32. PubMed ID: 19270694
[TBL] [Abstract][Full Text] [Related]
5. Targeting the oncogenic E3 ligase Skp2 in prostate and breast cancer cells with a novel energy restriction-mimetic agent.
Wei S; Chu PC; Chuang HC; Hung WC; Kulp SK; Chen CS
PLoS One; 2012; 7(10):e47298. PubMed ID: 23071779
[TBL] [Abstract][Full Text] [Related]
6. Phosphorylation of Ser72 does not regulate the ubiquitin ligase activity and subcellular localization of Skp2.
Boutonnet C; Tanguay PL; Julien C; Rodier G; Coulombe P; Meloche S
Cell Cycle; 2010 Mar; 9(5):975-9. PubMed ID: 20160482
[TBL] [Abstract][Full Text] [Related]
7. Molecular dynamics simulations elucidate the mode of protein recognition by Skp1 and the F-box domain in the SCF complex.
Chandra Dantu S; Nathubhai Kachariya N; Kumar A
Proteins; 2016 Jan; 84(1):159-71. PubMed ID: 26573739
[TBL] [Abstract][Full Text] [Related]
8. The Skp2 Pathway: A Critical Target for Cancer Therapy.
Cai Z; Moten A; Peng D; Hsu CC; Pan BS; Manne R; Li HY; Lin HK
Semin Cancer Biol; 2020 Dec; 67(Pt 2):16-33. PubMed ID: 32014608
[TBL] [Abstract][Full Text] [Related]
9. The G1 phase E3 ubiquitin ligase TRUSS that gets deregulated in human cancers is a novel substrate of the S-phase E3 ubiquitin ligase Skp2.
Jamal A; Swarnalatha M; Sultana S; Joshi P; Panda SK; Kumar V
Cell Cycle; 2015; 14(16):2688-700. PubMed ID: 26038816
[TBL] [Abstract][Full Text] [Related]
10. The role of Skp2 and its substrate CDKN1B (p27) in colorectal cancer.
Bochis OV; Irimie A; Pichler M; Berindan-Neagoe I
J Gastrointestin Liver Dis; 2015 Jun; 24(2):225-34. PubMed ID: 26114183
[TBL] [Abstract][Full Text] [Related]
11. Skp2 regulates the antiproliferative function of the tumor suppressor RASSF1A via ubiquitin-mediated degradation at the G1-S transition.
Song MS; Song SJ; Kim SJ; Nakayama K; Nakayama KI; Lim DS
Oncogene; 2008 May; 27(22):3176-85. PubMed ID: 18071316
[TBL] [Abstract][Full Text] [Related]
12. Regulation of Skp2 levels by the Pim-1 protein kinase.
Cen B; Mahajan S; Zemskova M; Beharry Z; Lin YW; Cramer SD; Lilly MB; Kraft AS
J Biol Chem; 2010 Sep; 285(38):29128-37. PubMed ID: 20663873
[TBL] [Abstract][Full Text] [Related]
13. Dysregulated expression of SKP2 and its role in hematological malignancies.
Kulinski M; Achkar IW; Haris M; Dermime S; Mohammad RM; Uddin S
Leuk Lymphoma; 2018 May; 59(5):1051-1063. PubMed ID: 28797197
[TBL] [Abstract][Full Text] [Related]
14. Regulation of neddylation and deneddylation of cullin1 in SCFSkp2 ubiquitin ligase by F-box protein and substrate.
Bornstein G; Ganoth D; Hershko A
Proc Natl Acad Sci U S A; 2006 Aug; 103(31):11515-20. PubMed ID: 16861300
[TBL] [Abstract][Full Text] [Related]
15. Human CUL-1 associates with the SKP1/SKP2 complex and regulates p21(CIP1/WAF1) and cyclin D proteins.
Yu ZK; Gervais JL; Zhang H
Proc Natl Acad Sci U S A; 1998 Sep; 95(19):11324-9. PubMed ID: 9736735
[TBL] [Abstract][Full Text] [Related]
16. Association of human CUL-1 and ubiquitin-conjugating enzyme CDC34 with the F-box protein p45(SKP2): evidence for evolutionary conservation in the subunit composition of the CDC34-SCF pathway.
Lisztwan J; Marti A; Sutterlüty H; Gstaiger M; Wirbelauer C; Krek W
EMBO J; 1998 Jan; 17(2):368-83. PubMed ID: 9430629
[TBL] [Abstract][Full Text] [Related]
17. FBXO43 promotes cell cycle progression in cancer cells through stabilizing SKP2.
Zheng L; Shen J; Chen Y; Lin J; Li P; Zhao X; Ren H; Sun Y; Wang Z
Cancer Lett; 2024 Jun; 591():216848. PubMed ID: 38604312
[TBL] [Abstract][Full Text] [Related]
18. Skp2-Mediated Stabilization of MTH1 Promotes Survival of Melanoma Cells upon Oxidative Stress.
Wang JY; Liu GZ; Wilmott JS; La T; Feng YC; Yari H; Yan XG; Thorne RF; Scolyer RA; Zhang XD; Jin L
Cancer Res; 2017 Nov; 77(22):6226-6239. PubMed ID: 28947420
[TBL] [Abstract][Full Text] [Related]
19. E3 ubiquitin ligase Skp2 as an attractive target in cancer therapy.
Hao Z; Huang S
Front Biosci (Landmark Ed); 2015 Jan; 20(3):474-90. PubMed ID: 25553462
[TBL] [Abstract][Full Text] [Related]
20. Pharmacogenomics and chemical library screens reveal a novel SCF
Malek E; Abdel-Malek MA; Jagannathan S; Vad N; Karns R; Jegga AG; Broyl A; van Duin M; Sonneveld P; Cottini F; Anderson KC; Driscoll JJ
Leukemia; 2017 Mar; 31(3):645-653. PubMed ID: 27677741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
